Spravato Marketing: How to Reach the Patients Who Actually Qualify

Rhys Mcculloch • November 11, 2026

Share this article

Quick answer: Spravato marketing fails when it chases volume. Spravato has narrow eligibility, so a campaign that brings in lots of general "depression help" enquiries mostly fills your schedule with people who don't qualify. The clinics that win treat marketing as a filter, not a net: they target the specific patient Spravato is approved for, qualify hard before anyone books, and measure treatment starts rather than enquiries. This post explains how.

Why is Spravato marketing different from normal clinic marketing?

Because the patient has to clear a bar before they can be treated at all.

Spravato (esketamine) is FDA-approved for treatment-resistant depression, which means the patient must usually have tried two or more antidepressants without adequate relief. Under the FDA's REMS safety programme, it can only be given in a certified healthcare setting, and the patient is monitored for at least two hours after each dose. Most commercial and government insurance plans cover it, but only with prior authorization.

Every one of those facts changes the marketing. You are not looking for "anyone feeling low." You are looking for a specific person: already diagnosed, already medicated, still not well, and able to come into the clinic regularly. Market wider than that and you pay for clicks from people who can never become patients.

Who is the Spravato patient you should actually target?

The qualifying patient sits inside a tight set of conditions. Your messaging and your targeting should speak to them and quietly screen everyone else out.

The patient who qualifies
The enquiry that wastes your time
Diagnosed with depression
Looking for a diagnosis
Has tried two or more antidepressants
Has never been on medication
Still not getting relief
Doing well on their current treatment
Able to attend in-clinic sessions and wait two hours
Wants an at-home or one-off option
Has commercial or government insurance
Expecting it to be free or cash-only cheap

Why do Spravato campaigns generate so many unqualified leads?

Because generic depression messaging pulls in everyone, and most of them don't qualify.

Run an ad that says "struggling with depression? we can help" and you will get enquiries. You will also get sixteen-year-olds, people who have never tried medication, people doing fine who just had a bad week, and people who want something they can do at home. Your front desk then spends its week sorting through them to find the few who were ever eligible. We cover the cost of that in Why Your Contact Form Is Costing You Patients.

The fix is not more ad spend. It is tighter targeting at the top and a qualification step before the booking, so only people who clear the Spravato bar reach your calendar.

See what’s costing you patients

Most clinics have three or four fixable gaps quietly losing them patients. See yours.

How do you qualify a Spravato enquiry before they book?

You put the questions your front desk would ask anyway in front of the patient first, as a short survey that replaces the contact form.

A qualification survey asks about diagnosis, prior medications, and whether they can attend in-clinic sessions, before anyone on your team spends a minute on them. Patients who clear the bar go straight to the top of your pipeline. Patients who don't get a respectful answer and a path to a different service, instead of a wasted consult slot. It runs day and night, so the Sunday-evening enquiry is sorted by the time you open on Monday.

This matters more for Spravato than almost any other treatment, precisely because the eligibility rules are strict. A qualification step turns "we got forty enquiries" into "we got nine people who actually qualify," which is the number that fills your chairs.

What should you measure?

Treatment starts, not enquiries. A Spravato enquiry count will always look healthy if your targeting is loose, because loose targeting is cheap. What tells you the marketing is working is how many of those enquiries become patients who complete prior authorization and begin treatment. We pull that argument apart in Enquiries Are the Wrong Number, and it applies doubly here, because the gap between "enquired" and "qualified and authorised" is wider for Spravato than for anything else you offer.

Frequently asked questions

Does insurance cover Spravato?

Most commercial and government plans do, but almost always with prior authorization, which the patient and clinic arrange before treatment. Your marketing should set this expectation early, so patients aren't surprised by the paperwork step.

Can I advertise Spravato by name?

You can market your Spravato service, but ad platforms apply extra scrutiny to prescription treatments and controlled substances, and your messaging has to stay within medical advertising rules. The safer, and usually more effective, approach is to lead with the patient's situation (treatment-resistant depression) rather than pushing the drug name hard.

Why are my Spravato leads such poor quality?

Usually because the targeting and the intake are too broad. Generic depression messaging with a plain contact form pulls in everyone, most of whom don't meet the eligibility criteria. Narrower targeting plus a qualification survey fixes it.

How is marketing Spravato different from marketing IV ketamine?

Spravato is FDA-approved, in-clinic, and usually insurance-covered, while IV ketamine is off-label and almost always cash-pay. That changes who you target and what you say. We break the comparison down in TMS vs Spravato vs IV Ketamine.

See where your Spravato marketing is leaking

Our free scan checks your clinic's online presence and flags what's quietly stopping qualified patients from booking, in plain language, with no call required. It takes about three minutes, and it will show you where tighter targeting and a qualification step would win you more treatment starts.

Recent Posts

Green marketing slide reading “What TMS marketing actually costs” with smaller text “Real numbers. No hedging.”
By team • November 3, 2026
for most TMS clinics, a marketing setup that actually brings in booked, qualified patients runs somewhere between roughly $860 and $3,500 a month, plus a one...
Dark green campaign slide with white text: “Enquiries are the wrong number. Track treatment starts, not leads.”
By Rhys Mcculloch • November 3, 2026
the number most TMS clinics watch, how many enquiries or leads they get, is the wrong one. A clinic drowning in enquiries can still be starving for patients,...
By Rhys Mcculloch • July 9, 2026
You're spending real money on ads. Patients are filling out the form on your website. The enquiries are coming in. Then the front desk picks up the phone, runs through the same questions for the tenth time that week, and discovers the person on the other end is sixteen, or hasn't tried any antidepressants yet, or is currently being treated by their existing psychiatrist and just wanted to ask a question. That's not a clinic problem. That's a form problem. A generic "contact us" form is doing the only job it knows how to do - collect a name, email, and phone number and send them through. It can't tell the difference between a strong TMS candidate and someone who's not eligible. It treats all of them the same way. And that means every consult slot, every front-desk callback, and every clinician hour is being spent on a pile of leads that haven't been sorted, even though some of them are weeks away from being treated and others were never going to be your patient. The cost of that shows up everywhere. Clinicians burn time on consults that should never have been booked. Front-desk staff spend their day chasing people who don't pick up. Genuine high-fit patients wait longer for callbacks than they should, and some of them lose patience and go to a competitor before you ever speak to them. The ad spend doesn't go down. The number of patients actually starting treatment does. The fix isn't more marketing. It's a smarter intake. What a qualification survey actually does differently A qualification survey replaces the contact form on your enquiry pages with a short, structured set of questions a patient answers before any of your team sees their name. By the time the enquiry reaches your CRM, it's already sorted, tagged, safety-screened, and routed. It works because it asks the things your front desk would ask anyway - diagnosis, prior medications, age, contraindications - but it asks them up front, in a way that turns answers into actions. Strong candidates go straight to the top of the pipeline. People who need a clinician to review something get held in a separate bucket. People who aren't candidates today get a respectful response and a follow-up sequence instead of a wasted consult slot. Under-18s are always routed to a human, never auto-approved. The patient finishes the survey, sees a result that matches their situation, and gets an email and a next step within seconds - at 2am, 11pm Sunday, or in the middle of a Tuesday afternoon.
By Rhys Mcculloch • June 30, 2026
Most TMS clinics spend their marketing energy on the first half of the problem - getting found. SEO, Google Ads, local listings, AI search visibility. All of it is built around the same goal: showing up when a patient searches. Then the patient lands on the website, looks around for ninety seconds, and leaves. Showing up is the table stakes. It's not the conversion. Between a patient finding your clinic and a patient picking up the phone, there's a trust layer most TMS websites skip past - and that's where the consults are quietly being lost. Here's what patients are actually looking for in those ninety seconds, and why most clinic sites don't give it to them. Getting these trust signals right is part of what your marketing budget buys. Here’s what TMS clinic marketing actually costs to put the whole system in place.
Green promo graphic for Build for Patriots: “How to Test Whether AI Search Knows Your Business” with smiling speaker on right
By Rhys Mcculloch • June 13, 2026
Customers are no longer starting on Google. A growing share of them open ChatGPT, Perplexity, or Google's AI Overviews, type a question - "best [your service] near me," "who should I use for X," "what's the best [product] for [situation]" - and read the answer. Two or three businesses get named.  The rest are invisible. That invisibility is the unsettling part. When you lose a Google ranking, you see it happen in your analytics. When an AI tool recommends your competitor to a thousand potential customers, nothing shows up in any report you currently run. Ranking well on Google does not mean you'll be cited by AI. Research suggests the overlap between top Google results and AI-cited sources is shrinking fast. You can be the number-one organic result and still never get mentioned in the answer. The first step isn't to fix it. It's to find out where you stand. Here's how to do that in under an hour.
Man in black shirt on green background beside text: “Why TMS clinics lose patients after the enquiry comes in”
By Rhys Mcculloch • June 1, 2026
Most TMS clinics spend their marketing budget getting patients to enquire. The website, the SEO, the ads - all of it exists to turn a stranger into someone who picks up the phone or fills in a form. Then the enquiry comes in, and the system that worked so hard to create it quietly drops the ball. This is the part of patient acquisition almost no clinic measures, and it's where a lot of expensive marketing goes to die. You can have the best website in your market and still lose the patient in the gap between "I'm interested" and "I've booked." Here's how that gap opens up, and what closing it actually looks like. The patient isn't waiting for you. They're comparing you. When someone enquires about TMS, they are rarely enquiring with one clinic. They're anxious, they've usually exhausted other treatment options, and they're doing what anyone does with a high-stakes decision - looking at several providers at once. That changes everything about what happens next. The patient who fills in your form at 2pm isn't sitting by the phone hoping you call back. They've also messaged the clinic across town, and maybe a third. Whoever responds first, clearly, and warmly is the one who gets the conversation. The others are competing for a patient who's already half-committed elsewhere. The research on this is consistent across industries: the large majority of customers end up going with whoever responds first - not the cheapest, not the most credentialed, but the first. For a TMS clinic, that means the quality of your care is irrelevant to the patient who never heard back in time to consider it. Speed is the variable nobody is managing The uncomfortable truth is that most clinics have no idea how fast they respond to enquiries, because nobody owns the number. A form comes in. It lands in an inbox that someone checks between patients. A voicemail sits until the front desk has a quiet moment. An after-hours enquiry waits until the next morning - by which point the patient has already spoken to someone else. None of this is negligence. It's just what happens when enquiry response is everybody's job and therefore nobody's job. The marketing generated the lead; the clinical team is busy treating patients; the front desk is managing a waiting room. The enquiry falls into the space between them. The clinics that convert well aren't working harder. They've simply decided that responding to an enquiry is a defined job with a defined target - minutes, not hours - and built a small amount of process around making that happen reliably. After-hours is where the most patients are lost Here's the part that's easy to miss. A meaningful share of TMS enquiries arrive outside clinic hours - evenings, weekends, the moments when someone finally sits down, opens their laptop, and decides to do something about how they've been feeling. That timing is not a coincidence. It's often when the patient is most motivated. And it's exactly when most clinics are least equipped to respond. If your only response mechanism is a person checking an inbox during business hours, every evening and weekend enquiry cools for twelve hours or more before anyone touches it. By Monday morning, the patient who enquired on Friday night has had a whole weekend to talk to a competitor, change their mind, or lose the nerve it took to reach out in the first place. This is the single biggest fixable leak in most clinics' patient acquisition, and it has nothing to do with the website.. Working out your cost per treatment start only means something once you know what the marketing itself costs to run.
Two people discussing a laptop at a wooden table in a cafe
By Rhys Mcculloch • May 20, 2026
For a clinic offering more than one interventional psychiatry treatment, the patient on your website isn't asking "should I try TMS?" - they're asking "which of these is right for me?" That second question is harder. It's also the one most clinic websites quietly fail to answer. This post is about the cross-treatment decision logic patients are actually running through when they land on your site — and what a website built for that decision looks like in practice. What are patients comparing when they land on your site A patient researching interventional psychiatry rarely arrives knowing which treatment they want. They arrive somewhere along this spectrum: They've tried two or three medications, none of which have worked well, and a friend or their psychiatrist mentioned "you should look into TMS or Spravato" They've read about ketamine therapy somewhere and want to know if it's the same as Spravato (it's not, quite) They've heard about accelerated TMS or SAINT and want to know if that's faster than the standard protocol They've seen Spravato advertised, called their insurance, and are now confused about whether they qualify The thing every one of those patients has in common: they're comparing treatments before they're comparing clinics. A typical example: a clinic offers TMS, Spravato, and IV ketamine. The website has three service pages, three different contact forms, and a single "Book a Consultation" CTA across all of them. A patient with treatment-resistant depression lands on the homepage, doesn't know which of the three applies to her, opens all three service pages in separate tabs, and leaves twenty minutes later more confused than when she arrived. None of the three pages helped her choose. That's the gap. If your website only presents TMS, Spravato, and IV ketamine as three separate service pages with their own CTAs, the patient still has to do the comparison work themselves. Most won't. They'll leave, go to Reddit or WebMD, and come back to a different clinic that helped them choose. The three decisions patients are actually making Each cross-treatment comparison comes down to a specific set of questions. Clinic websites that convert well address each one directly. TMS vs antidepressant medication Most patients arriving at an interventional psychiatry clinic have been on medication for a while and aren't getting the response they hoped for. They want to know: Is TMS a replacement for my medication, or do I stay on it? How is the effect different from a new pill? Will the relief last after the six-week course ends? What does the day-to-day actually look like compared to taking a pill? Most TMS service pages explain the neurological mechanism. Almost none explain what the patient should expect compared to their current medication. That gap is where the inquiry is lost. Spravato vs IV ketamine This is the comparison most likely to be searched and least likely to be answered well on clinic websites. The two treatments are pharmacologically related but operationally very different: Spravato is FDA-cleared for treatment-resistant depression, administered in-clinic as a nasal spray, observed for two hours after each dose, and covered by most commercial and government insurance plans with prior authorization.  IV ketamine is administered as an infusion, typically over 40 minutes, and is almost always cash-pay because most insurance plans don't cover off-label ketamine infusions for depression.
TMS clinic illustration with clinician, patient in treatment chair, and a pricing dashboard asking if prices should be public
By Rhys Mcculloch • April 30, 2026
The short answer is yes. The longer, more useful answer is that the question is the wrong question. The clinics' ranking for searches like "accelerated TMS cost" has already moved on from that debate - their pricing is on the page. The question they're asking is harder: How do you publish pricing when fees vary by insurance, protocol, income, and whether the patient prepays? That's what this post is about. Not whether to publish - that ship has sailed - but how to do it without losing insurance-paying patients or painting yourself into a corner you can't update later. Why "we work with most major insurers" doesn't count Most TMS clinic websites have something that gestures vaguely at pricing. "We accept most major insurers." "Contact us for a personalised quote." "Costs vary depending on your treatment plan." That's not transparency. It's hedging dressed up as helpfulness. A patient searching "how much does TMS cost" doesn't need to be told that costs vary. They know that. They want a number (any number) to anchor their thinking against. Without one, they leave and find a clinic that gives them one. Increasingly, that's also what Google rewards. Search any high-intent TMS cost query, and the top organic results are clinics publishing real figures. The clinics still hedging are nowhere on the first page. Pricing patients see is only part of the picture. For the full breakdown of what TMS clinic marketing costs, we lay out real numbers here.
Two people are discussing a laptop at a wooden table in a modern office setting.
By Leo Cook • April 27, 2026
Transcranial Magnetic Stimulation is one of the fastest-growing treatment categories in mental health. Search interest for "TMS near me" and "TMS therapy" has climbed steadily over the past three years, and most established clinics are seeing more patient awareness than they did even twelve months ago. But traffic is not the problem most clinics have. We've worked with TMS and interventional psychiatry providers across the US -such as Inspire TMS Denver and Evolve Brain Health - and the same pattern shows up across nearly every site we audit before we rebuild it. The traffic is there. The enquiries are not. Here is what is actually breaking, and what to do about it. The site explains TMS, but does not guide a decision Most TMS websites are written by clinicians, for clinicians. They explain the magnetic coil, the neurological mechanism, the pulse Hz, and the FDA clearance history. The patient on the other end is not asking any of that. They are asking: Will this work if my medication hasn't? Am I even eligible? How soon can I start? What does insurance actually cover? How disruptive is this going to be to my life? Suppose the homepage and the main service page do not answer those questions in the first scroll, the visitor leaves. Not because the science is uninteresting, but because the science is not what they came for. Fix: Lead with patient intent. Eligibility, outcomes, and next step go above the fold. Clinical details belong further down the page for the patients who want them.